RxDoctor Payments Data

Kelley Dawley, NP

Nurse Practitioner · W Burlington, IANPI 1821468927

Payments from drug & device makers

$454in general payments, 2019–2025

Across 25 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$216
  • Novo Nordisk$67
  • Teva Pharmaceuticals USA, Inc.$33
  • Lilly USA, LLC$27
  • Eisai Inc.$24
  • GSK$19
  • plus $68 from 4 others

What the payments were for

  • Food & beverage$454100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$454 in reported general payments places this provider in the 75th percentile of 1,346 nurse practitioner providers in Iowa.

See all nurse practitioner providers in Iowa

Medicare billing

Part B allowed, 2024
$12,017
Medicare patients
24
Services billed
678

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant32$46,403
Nurtec OdtRimegepant Sulfate26$30,347
QuliptaAtogepant14$16,421
OzempicSemaglutide12$15,040
RybelsusSemaglutide14$12,792
EliquisApixaban15$11,088
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog23$10,084
JanuviaSitagliptin Phosphate11$8,643
Lantus SolostarInsulin Glargine,hum.Rec.Anlog43$3,695
Memantine Hcl43$2,625
Sucralfate14$2,354
Pantoprazole Sodium40$2,225
Novolog FlexpenInsulin Aspart13$1,771
Omeprazole132$1,409
Gabapentin100$1,042

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$216$62,82446 claims
PfizerNurtec Odt, Eliquis$16$41,43541 claims
Novo NordiskOzempic, Rybelsus$67$27,83226 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,346 nurse practitioner providers in Iowa.

Other nurse practitioner in W Burlington

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →